Abstract
One of the main reasons for cancer mortality is caused by the highly invasive behavior of cancer cells, which often due to aggressive metastasis. Metastasis is mediated by various growth factors and cytokines, operating through numerous signaling pathways. Remarkably, all these metastatic signaling pathways must enter the nucleus through a single gatekeeper, the nuclear pore complex (NPC). NPCs are the only gateway between the cytoplasm and the nucleus. NPCs are among the largest proteinaceous assemblies in the cell and are composed of multiple copies of around 30 different proteins called nucleoporins. Here, we review what is currently known about the NPC, and its role in the mechanisms of tumor progression. We will also explore potential strategies to target metastatic pathways by manipulating the karyopherins (importins/exportins) of nucleocytoplasmic traffic through NPCs.
Similar content being viewed by others
References
Murphy, P. M. (2001). Chemokines and the molecular basis of cancer metastasis. The New England Journal of Medicine, 345, 833–835.
Khan, N., & Mukhtar, H. (2010). Cancer and metastasis: Prevention and treatment by green tea. Cancer and Metastasis Reviews, 29, 435–445.
Steeg, P. S. (2006). Tumor metastasis: Mechanistic insights and clinical challenges. Natural Medicines, 12, 895–904.
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2, 563–572.
Chiang, A. C., & Massague, J. (2008). Molecular basis of metastasis. The New England Journal of Medicine, 359, 2814–2823.
Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Lancet, 1, 571–573.
Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Cancer and Metastasis Reviews, 8, 98–101.
Funasaka, T., & Raz, A. (2007). The role of autocrine motility factor in tumor and tumor microenvironment. Cancer and Metastasis Reviews, 26, 725–735.
Krug, E. L., Mjaatvedt, C. H., & Markwald, R. R. (1987). Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. Developmental Biology, 120, 348–355.
Hay, E. D. (1995). An overview of epithelio-mesenchymal transformation. Acta Anat Basel, 154, 8–20.
Finger, E. C., & Giaccia, A. J. (2010). Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer and Metastasis Reviews, 29, 285–293.
Gravdal, K., Halvorsen, O. J., Haukaas, S. A., & Akslen, L. A. (2007). A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clinical Cancer Research, 13, 7003–7011.
Margulis, A., Zhang, W., Alt-Holland, A., Crawford, H. C., Fusenig, N. E., & Garlick, J. A. (2005). E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Research, 65, 1783–1791.
Yilmaz, M., & Christofori, G. (2009). EMT, the cytoskeleton, and cancer cell invasion. Cancer and Metastasis Reviews, 28, 15–33.
Dumont, N., Bakin, A. V., & Arteaga, C. L. (2003). Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells. The Journal of Biological Chemistry, 278, 3275–3285.
Strambio-De-Castillia, C., Niepel, M., & Rout, M. P. (2010). The nuclear pore complex: Bridging nuclear transport and gene regulation. Nature Reviews. Molecular Cell Biology, 11, 490–501.
Xu, S., & Powers, M. A. (2009). Nuclear pore proteins and cancer. Seminars in Cell & Developmental Biology, 20, 620–630.
Tran, E. J., & Wente, S. R. (2006). Dynamic nuclear pore complexes: Life on the edge. Cell, 125, 1041–1053.
Hetzer, M. W. (2010). The nuclear envelope. Cold Spring Harb Perspect Biol, 2, a000539.
Hetzer, M. W., & Wente, S. R. (2009). Border control at the nucleus: Biogenesis and organization of the nuclear membrane and pore complexes. Developmental Cell, 17, 606–616.
Lim, R. Y., Aebi, U., & Fahrenkrog, B. (2008). Towards reconciling structure and function in the nuclear pore complex. Histochemistry and Cell Biology, 129, 105–116.
Schwartz, T. U. (2005). Modularity within the architecture of the nuclear pore complex. Current Opinion in Structural Biology, 15, 221–226.
Rout, M. P., Aitchison, J. D., Suprapto, A., Hjertaas, K., Zhao, Y., & Chait, B. T. (2000). The yeast nuclear pore complex: Composition, architecture, and transport mechanism. The Journal of Cell Biology, 148, 635–651.
Blobel, G. (2010) Three-dimensional organization of chromatids by nuclear envelope-associated structures. Cold Spring Harb Symp Quant Biol.
Brown, J. A., Bharathi, A., Ghosh, A., Whalen, W., Fitzgerald, E., & Dhar, R. (1995). A mutation in the Schizosaccharomyces pombe rae1 gene causes defects in poly(A) + RNA export and in the cytoskeleton. The Journal of Biological Chemistry, 270, 7411–7419.
Kraemer, D., & Blobel, G. (1997). mRNA binding protein mrnp 41 localizes to both nucleus and cytoplasm. Proceedings of the National Academy of Sciences of the United States of America, 94, 9119–9124.
Murphy, R., Watkins, J. L., & Wente, S. R. (1996). GLE2, a Saccharomyces cerevisiae homologue of the Schizosaccharomyces pombe export factor RAE1, is required for nuclear pore complex structure and function. Molecular Biology of the Cell, 7, 1921–1937.
Bailer, S. M., Siniossoglou, S., Podtelejnikov, A., Hellwig, A., Mann, M., & Hurt, E. (1998). Nup116p and nup100p are interchangeable through a conserved motif which constitutes a docking site for the mRNA transport factor gle2p. The EMBO Journal, 17, 1107–1119.
Pritchard, C. E., Fornerod, M., Kasper, L. H., & van Deursen, J. M. (1999). RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains. The Journal of Cell Biology, 145, 237–254.
Ren, Y., Seo, H. S., Blobel, G., & Hoelz, A. (2010). Structural and functional analysis of the interaction between the nucleoporin Nup98 and the mRNA export factor Rae1. Proceedings of the National Academy of Sciences of the United States of America, 107, 10406–10411.
Paoli, M. (2001). Protein folds propelled by diversity. Progress in Biophysics and Molecular Biology, 76, 103–130.
Blower, M. D., Nachury, M., Heald, R., & Weis, K. (2005). A Rae1-containing ribonucleoprotein complex is required for mitotic spindle assembly. Cell, 121, 223–234.
Wong, R. W. (2010). Interaction between Rae1 and cohesin subunit SMC1 is required for proper spindle formation. Cell Cycle, 9, 198–200.
Wong, R. W. (2010). An update on cohesin function as a ‘molecular glue’ on chromosomes and spindles. Cell Cycle, 9, 1754–1758.
Wong, R. W., & Blobel, G. (2008). Cohesin subunit SMC1 associates with mitotic microtubules at the spindle pole. Proceedings of the National Academy of Sciences of the United States of America, 105, 15441–15445.
Wong, R. W., Blobel, G., & Coutavas, E. (2006). Rae1 interaction with NuMA is required for bipolar spindle formation. Proceedings of the National Academy of Sciences of the United States of America, 103, 19783–19787.
Guttinger, S., Laurell, E., & Kutay, U. (2009). Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nature Reviews. Molecular Cell Biology, 10, 178–191.
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W. L., et al. (2006). Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell, 10, 529–541.
Moore, M. A. (2010). A cancer fate in the hands of a samurai. Natural Medicines, 16, 963–965.
Moore, M. A., Chung, K. Y., Plasilova, M., Schuringa, J. J., Shieh, J. H., Zhou, P., et al. (2007). NUP98 dysregulation in myeloid leukemogenesis. Annals of the New York Academy of Sciences, 1106, 114–142.
Radu, A., Moore, M. S., & Blobel, G. (1995). The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex. Cell, 81, 215–222.
Fontoura, B. M., Blobel, G., & Matunis, M. J. (1999). A conserved biogenesis pathway for nucleoporins: Proteolytic processing of a 186-kilodalton precursor generates Nup98 and the novel nucleoporin, Nup96. The Journal of Cell Biology, 144, 1097–1112.
Vasu, S., Shah, S., Orjalo, A., Park, M., Fischer, W. H., & Forbes, D. J. (2001). Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export. The Journal of Cell Biology, 155, 339–354.
Griffis, E. R., Altan, N., Lippincott-Schwartz, J., & Powers, M. A. (2002). Nup98 is a mobile nucleoporin with transcription-dependent dynamics. Molecular Biology of the Cell, 13, 1282–1297.
Wu, X., Kasper, L. H., Mantcheva, R. T., Mantchev, G. T., Springett, M. J., & van Deursen, J. M. (2001). Disruption of the FG nucleoporin NUP98 causes selective changes in nuclear pore complex stoichiometry and function. Proceedings of the National Academy of Sciences of the United States of America, 98, 3191–3196.
Blevins, M. B., Smith, A. M., Phillips, E. M., & Powers, M. A. (2003). Complex formation among the RNA export proteins Nup98, Rae1/Gle2, and TAP. The Journal of Biological Chemistry, 278, 20979–20988.
Jeganathan, K. B., Baker, D. J., & van Deursen, J. M. (2006). Securin associates with APCCdh1 in prometaphase but its destruction is delayed by Rae1 and Nup98 until the metaphase/anaphase transition. Cell Cycle, 5, 366–370.
Jeganathan, K. B., Malureanu, L., & van Deursen, J. M. (2005). The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation. Nature, 438, 1036–1039.
Wozniak, R., Burke, B., & Doye, V. (2010). Nuclear transport and the mitotic apparatus: An evolving relationship. Cellular and Molecular Life Sciences, 67, 2215–2230.
Cross, M.K., & Powers, M.A. (2011) Nup98 regulates bipolar spindle assembly through association with microtubules and opposition of MCAK. Mol Biol Cell. in press.
Nakamura, T., Largaespada, D. A., Lee, M. P., Johnson, L. A., Ohyashiki, K., Toyama, K., et al. (1996). Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nature Genetics, 12, 154–158.
Borrow, J., Shearman, A. M., Stanton, V. P., Jr., Becher, R., Collins, T., Williams, A. J., et al. (1996). The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nature Genetics, 12, 159–167.
Moore, M. A. (2005). Converging pathways in leukemogenesis and stem cell self-renewal. Experimental Hematology, 33, 719–737.
Krull, S., Thyberg, J., Bjorkroth, B., Rackwitz, H. R., & Cordes, V. C. (2004). Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket. Molecular Biology of the Cell, 15, 4261–4277.
Byrd, D. A., Sweet, D. J., Pante, N., Konstantinov, K. N., Guan, T., Saphire, A. C., et al. (1994). Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. The Journal of Cell Biology, 127, 1515–1526.
Cordes, V. C., Reidenbach, S., Rackwitz, H. R., & Franke, W. W. (1997). Identification of protein p270/Tpr as a constitutive component of the nuclear pore complex-attached intranuclear filaments. The Journal of Cell Biology, 136, 515–529.
Fontoura, B. M., Dales, S., Blobel, G., & Zhong, H. (2001). The nucleoporin Nup98 associates with the intranuclear filamentous protein network of TPR. Proceedings of the National Academy of Sciences of the United States of America, 98, 3208–3213.
Frosst, P., Guan, T., Subauste, C., Hahn, K., & Gerace, L. (2002). Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. The Journal of Cell Biology, 156, 617–630.
Lee, S. H., Sterling, H., Burlingame, A., & McCormick, F. (2008). Tpr directly binds to Mad1 and Mad2 and is important for the Mad1-Mad2-mediated mitotic spindle checkpoint. Genes & Development, 22, 2926–2931.
Nakano, H., Funasaka, T., Hashizume, C., & Wong, R. W. (2010). Nucleoporin translocated promoter region (Tpr) associates with dynein complex, preventing chromosome lagging formation during mitosis. The Journal of Biological Chemistry, 285, 10841–10849.
Strambio-de-Castillia, C., Blobel, G., & Rout, M. P. (1999). Proteins connecting the nuclear pore complex with the nuclear interior. The Journal of Cell Biology, 144, 839–855.
Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., et al. (1984). Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature, 311, 29–33.
Park, M., Dean, M., Cooper, C. S., Schmidt, M., O’Brien, S. J., Blair, D. G., et al. (1986). Mechanism of met oncogene activation. Cell, 45, 895–904.
Peschard, P., & Park, M. (2007). From Tpr-Met to Met, tumorigenesis and tubes. Oncogene, 26, 1276–1285.
Macaulay, C., Meier, E., & Forbes, D. J. (1995). Differential mitotic phosphorylation of proteins of the nuclear pore complex. The Journal of Biological Chemistry, 270, 254–262.
Martinez, N., Alonso, A., Moragues, M. D., Ponton, J., & Schneider, J. (1999). The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Research, 59, 5408–5411.
Gould, V. E., Martinez, N., Orucevic, A., Schneider, J., & Alonso, A. (2000). A novel, nuclear pore-associated, widely distributed molecule overexpressed in oncogenesis and development. The American Journal of Pathology, 157, 1605–1613.
Gould, V. E., Orucevic, A., Zentgraf, H., Gattuso, P., Martinez, N., & Alonso, A. (2002). Nup88 (karyoporin) in human malignant neoplasms and dysplasias: Correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Human Pathology, 33, 536–544.
Agudo, D., Gomez-Esquer, F., Martinez-Arribas, F., Nunez-Villar, M. J., Pollan, M., & Schneider, J. (2004). Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. International Journal of Cancer, 109, 717–720.
Bastos, R., Ribas de Pouplana, L., Enarson, M., Bodoor, K., & Burke, B. (1997). Nup84, a novel nucleoporin that is associated with CAN/Nup214 on the cytoplasmic face of the nuclear pore complex. The Journal of Cell Biology, 137, 989–1000.
van Deursen, J., Boer, J., Kasper, L., & Grosveld, G. (1996). G2 arrest and impaired nucleocytoplasmic transport in mouse embryos lacking the proto-oncogene CAN/Nup214. The EMBO Journal, 15, 5574–5583.
Walther, T. C., Pickersgill, H. S., Cordes, V. C., Goldberg, M. W., Allen, T. D., Mattaj, I. W., et al. (2002). The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein import. The Journal of Cell Biology, 158, 63–77.
von Moeller, H., Basquin, C., & Conti, E. (2009). The mRNA export protein DBP5 binds RNA and the cytoplasmic nucleoporin NUP214 in a mutually exclusive manner. Nature Structural & Molecular Biology, 16, 247–254.
Napetschnig, J., Kassube, S. A., Debler, E. W., Wong, R. W., Blobel, G., & Hoelz, A. (2009). Structural and functional analysis of the interaction between the nucleoporin Nup214 and the DEAD-box helicase Ddx19. Proceedings of the National Academy of Sciences of the United States of America, 106, 3089–3094.
von Lindern, M., Fornerod, M., van Baal, S., Jaegle, M., de Wit, T., Buijs, A., et al. (1992). The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Molecular and Cellular Biology, 12, 1687–1697.
von Lindern, M., van Baal, S., Wiegant, J., Raap, A., Hagemeijer, A., & Grosveld, G. (1992). Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: Characterization of the set gene. Molecular and Cellular Biology, 12, 3346–3355.
Fagerlund, R., Melen, K., Cao, X., & Julkunen, I. (2008). NF-kappaB p52, RelB and c-Rel are transported into the nucleus via a subset of importin alpha molecules. Cellular Signalling, 20, 1442–1451.
Weis, K. (2003). Regulating access to the genome: Nucleocytoplasmic transport throughout the cell cycle. Cell, 112, 441–451.
Lu, X., & Kang, Y. (2010). Epidermal growth factor signalling and bone metastasis. British Journal of Cancer, 102, 457–461.
Wang, Y. N., Yamaguchi, H., Hsu, J. M., & Hung, M. C. (2010). Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene, 29, 3997–4006.
Hynes, N. E., & MacDonald, G. (2009). ErbB receptors and signaling pathways in cancer. Current Opinion in Cell Biology, 21, 177–184.
Citri, A., & Yarden, Y. (2006). EGF-ERBB signalling: Towards the systems level. Nature Reviews. Molecular Cell Biology, 7, 505–516.
Lo, H. W., Ali-Seyed, M., Wu, Y., Bartholomeusz, G., Hsu, S. C., & Hung, M. C. (2006). Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. Journal of Cellular Biochemistry, 98, 1570–1583.
Vrailas-Mortimer, A. D., Majumdar, N., Middleton, G., Cooke, E. M., & Marenda, D. R. (2007). Delta and Egfr expression are regulated by Importin-7/Moleskin in Drosophila wing development. Developmental Biology, 308, 534–546.
Giri, D. K., Ali-Seyed, M., Li, L. Y., Lee, D. F., Ling, P., Bartholomeusz, G., et al. (2005). Endosomal transport of ErbB-2: Mechanism for nuclear entry of the cell surface receptor. Molecular and Cellular Biology, 25, 11005–11018.
Nguyen, D. X., Bos, P. D., & Massague, J. (2009). Metastasis: From dissemination to organ-specific colonization. Nature Reviews. Cancer, 9, 274–284.
Padua, D., & Massague, J. (2009). Roles of TGFbeta in metastasis. Cell Research, 19, 89–102.
Massague, J. (2008). TGFbeta in Cancer. Cell, 134, 215–230.
Miyazono, K. (2009). Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proceedings of the Japan Academy. Series B: Physical and Biological Sciences, 85, 314–323.
Roberts, A. B., Flanders, K. C., Heine, U. I., Jakowlew, S., Kondaiah, P., Kim, S. J., et al. (1990). Transforming growth factor-beta: Multifunctional regulator of differentiation and development. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 327, 145–154.
Kang, Y. (2006). Pro-metastasis function of TGFbeta mediated by the Smad pathway. Journal of Cellular Biochemistry, 98, 1380–1390.
Korpal, M., & Kang, Y. (2010). Targeting the transforming growth factor-beta signalling pathway in metastatic cancer. European Journal of Cancer, 46, 1232–1240.
Kang, J. S., Liu, C., & Derynck, R. (2009). New regulatory mechanisms of TGF-beta receptor function. Trends in Cell Biology, 19, 385–394.
Xu, L., Kang, Y., Col, S., & Massague, J. (2002). Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Molecular Cell, 10, 271–282.
Sukegawa, J., & Blobel, G. (1993). A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm. Cell, 72, 29–38.
Marg, A., Shan, Y., Meyer, T., Meissner, T., Brandenburg, M., & Vinkemeier, U. (2004). Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1. The Journal of Cell Biology, 165, 823–833.
Nakahara, S., Hogan, V., Inohara, H., & Raz, A. (2006). Importin-mediated nuclear translocation of galectin-3. The Journal of Biological Chemistry, 281, 39649–39659.
Nakahara, S., Oka, N., Wang, Y., Hogan, V., Inohara, H., & Raz, A. (2006). Characterization of the nuclear import pathways of galectin-3. Cancer Research, 66, 9995–10006.
Nakahara, S., & Raz, A. (2007). Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway. Cancer and Metastasis Reviews, 26, 605–610.
Henderson, B. R., & Fagotto, F. (2002). The ins and outs of APC and beta-catenin nuclear transport. EMBO Reports, 3, 834–839.
Thorne, M. E., & Gottardi, C. J. (2005). Terminating Wnt signals: A novel nuclear export mechanism targets activated (beta)-catenin. The Journal of Cell Biology, 171, 761–763.
Chachami, G., Paraskeva, E., Mingot, J. M., Braliou, G. G., Gorlich, D., & Simos, G. (2009). Transport of hypoxia-inducible factor HIF-1alpha into the nucleus involves importins 4 and 7. Biochemical and Biophysical Research Communications, 390, 235–240.
Pemberton, L. F., & Paschal, B. M. (2005). Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic, 6, 187–198.
Mylonis, I., Chachami, G., Paraskeva, E., & Simos, G. (2008). Atypical CRM1-dependent nuclear export signal mediates regulation of hypoxia-inducible factor-1alpha by MAPK. The Journal of Biological Chemistry, 283, 27620–27627.
Mylonis, I., Chachami, G., Samiotaki, M., Panayotou, G., Paraskeva, E., Kalousi, A., et al. (2006). Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. The Journal of Biological Chemistry, 281, 33095–33106.
Ghosh, S., May, M. J., & Kopp, E. B. (1998). NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annual Review of Immunology, 16, 225–260.
Muller, P. A., van de Sluis, B., Groot, A. J., Verbeek, D., Vonk, W. I., Maine, G. N., et al. (2009). Nuclear-cytosolic transport of COMMD1 regulates NF-kappaB and HIF-1 activity. Traffic, 10, 514–527.
Johnson, C., Van Antwerp, D., & Hope, T. J. (1999). An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. The EMBO Journal, 18, 6682–6693.
Carlotti, F., Dower, S. K., & Qwarnstrom, E. E. (2000). Dynamic shuttling of nuclear factor kappa B between the nucleus and cytoplasm as a consequence of inhibitor dissociation. The Journal of Biological Chemistry, 275, 41028–41034.
Birbach, A., Gold, P., Binder, B. R., Hofer, E., de Martin, R., & Schmid, J. A. (2002). Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. The Journal of Biological Chemistry, 277, 10842–10851.
Shenouda, S. K., & Alahari, S. K. (2009). MicroRNA function in cancer: Oncogene or a tumor suppressor? Cancer and Metastasis Reviews, 28, 369–378.
Castanotto, D., Lingeman, R., Riggs, A. D., & Rossi, J. J. (2009). CRM1 mediates nuclear-cytoplasmic shuttling of mature microRNAs. Proceedings of the National Academy of Sciences of the United States of America, 106, 21655–21659.
Lee, S.J., Jiko, C., Yamashita, E., & Tsukihara, T. (2011) Selective nuclear export mechanism of small RNAs. Curr Opin Struct Biol. in press.
Okamura, K., Hagen, J. W., Duan, H., Tyler, D. M., & Lai, E. C. (2007). The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell, 130, 89–100.
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449, 682–688.
Gee, H.E., Camps, C., Buffa, F. M., Colella, S., Sheldon, H., Gleadle, J.M., Ragoussis, J., Harris, A.L. (2008) MicroRNA-10b and breast cancer metastasis. Nature, 455, E8-9; author reply E9.
Nakano, H., Wang, W., Hashizume, C., Funasaka, T., Sato, H., & Wong, R. W. (2011). Unexpected role of nucleoporins in coordination of cell progression. Cell Cycle 10, 425–433
Acknowledgments
The authors regret the many publications we were unable to cite due to lack of space. This work was supported by the Program for Improvement of the Research Environment for Young Researchers from the Special Coordination Funds for Promoting Science and Technology (SCF), Grants-in-Aid for Scientific Research on Innovative Areas and Young Scientists from MEXT Japan, and by grants from the Asahi Glass Foundation, the Mochida Memorial Foundation, the Suzuken Memorial Foundation, the Kowa Life Science Foundation, the Takeda Science Foundation, the Astellas Foundation, and the Novartis Foundation (Japan) to RW.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Funasaka, T., Wong, R.W. The role of nuclear pore complex in tumor microenvironment and metastasis. Cancer Metastasis Rev 30, 239–251 (2011). https://doi.org/10.1007/s10555-011-9287-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-011-9287-y